We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$7.14B
Cap. Flow %
-8.9%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734

Sector Composition

Rank Sector Weight
1 Technology 12.69%
2 Industrials 9.96%
3 Consumer Discretionary 8.03%
4 Healthcare 7.46%
5 Financials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSP
2851
Franklin Street Properties
FSP
$45.2M
$6.81K ﹤0.01%
+13,229
New +$7.83K
MYPS icon
2852
PLAYSTUDIOS Inc
MYPS
$63.3M
$5.99K ﹤0.01%
+12,013
New +$5.78K
HAIN icon
2853
Hain Celestial
HAIN
$71.6M
$5.97K ﹤0.01%
+10,651
New +$7.9K
OPENL
2854
Opendoor Technologies Inc Series A Warrants
OPENL
$4.14M
$5.92K ﹤0.01%
20,938
-3,030
-13% -$930
OPENZ
2855
Opendoor Technologies Inc Series Z Warrants
OPENZ
$3.99M
$5.92K ﹤0.01%
24,661
CHTR icon
2856
Charter Communications
CHTR
$17.9B
$3.56K ﹤0.01%
25
-1,260
-98% -$210K
ARAY icon
2857
Accuray
ARAY
$33.6M
$3.35K ﹤0.01%
+13,007
New +$4.84K
RANI icon
2858
Rani Therapeutics
RANI
$102M
$1.68K ﹤0.01%
2,206
-3,693
-63% -$3.27K
CLPT icon
2859
ClearPoint Neuro
CLPT
$469M
$892 ﹤0.01%
+50
New +$625
AAT
2860
American Assets Trust
AAT
$1.4B
-13,181
Closed -$243K
ABCB icon
2861
Ameris Bancorp
ABCB
$5.78B
-4,587
Closed -$358K
ABEO icon
2862
Abeona Therapeutics
ABEO
$348M
-589,847
Closed -$2.64M
ABM icon
2863
ABM Industries
ABM
$2.74B
-25,886
Closed -$997K
ABUS icon
2864
Arbutus Biopharma
ABUS
$1.03B
-125,521
Closed -$565K
ACIW icon
2865
ACI Worldwide
ACIW
$5.24B
-25,301
Closed -$1.04M
ACLX
2866
DELISTED
Arcellx
ACLX
-479,763
Closed -$55.1M
ACMR icon
2867
ACM Research
ACMR
$5.53B
-47,076
Closed -$1.85M
ACM icon
2868
Aecom
ACM
$8.34B
-267,610
Closed -$22.7M
ADCT icon
2869
ADC Therapeutics
ADCT
$127M
-77,947
Closed -$292K
AEG icon
2870
Aegon
AEG
$13.3B
-81,736
Closed -$593K
AEHR icon
2871
Aehr Test Systems
AEHR
$3.32B
-16,262
Closed -$603K
AEO icon
2872
American Eagle Outfitters
AEO
$2.71B
-504,519
Closed -$8.43M
AFRM icon
2873
Affirm
AFRM
$25.8B
-1,149,661
Closed -$75.1M
AGIO icon
2874
Agios Pharmaceuticals
AGIO
$1.98B
-18,009
Closed -$609K
AGX icon
2875
Argan
AGX
$7.03B
-809
Closed -$441K

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.